SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

PDSB

PDS Biotechnology Corporation
NASDAQHealth Care

Latest close: 1.13 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 22, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 21, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record7273 flagged findings
Reported transactions (Form 4)42since Jul 14, 2023 · and 12 other holdings
Corporate events (8-K)30since May 2, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Jul 31, 2026).

Deadline: Jan 26, 2027

  • minimum bid price · Nasdaq, rule 5550(a)(2) · notice of Jul 30, 2026 · pending · deadline Jan 26, 2027 (text and rule agree)

The other times

Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.

Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.

Open the 8-K at the SEC

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 727)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 14, 26S-3 ↗Securities offering new
  • Oct 6, 268-K ↗Current report · Other events
  • Sep 22, 268-K ↗Current report · Other events
  • Sep 21, 26SCHEDULE 13D ↗Stake with intent to influence · Nant Capital, LLC · 19.9% · event on Sep 14, 26
  • Insider transaction · 2 Form 3 filingsshow all 2hide
  • Sep 21, 268-K ↗Current report · Other events
  • Sep 18, 26Form 3 ↗Insider transaction
  • Sep 14, 268-K ↗Current report · A material agreement was terminated
  • Sep 8, 268-K ↗Current report · Sold unregistered shares
  • Sep 4, 268-K ↗Current report · Entered a material agreement
  • Aug 25, 268-K ↗Current report · Restructuring plan with committed costs
  • Aug 19, 268-K ↗Current report · A senior executive left or was appointed
  • Aug 14, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results
  • Aug 11, 268-K ↗Current report · Communication to the market
  • Jul 31, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Jul 21, 26424B4 ↗Securities offering
  • Jul 10, 26S-3 ↗Securities offering
  • Jun 26, 26DEFA14A ↗Shareholder meeting and votes
  • Jun 26, 26DEF 14A ↗Shareholder meeting and votes
  • Jun 15, 26424B5 ↗Securities offering
  • Jun 15, 26PRE 14A ↗Shareholder meeting and votes
  • Jun 15, 268-K ↗Current report · Entered a material agreement

727 filings on record, the oldest from Apr 18, 14.

Listing the 25 most recent filings of the 727 on record.

8-Ks, explained

Stress7Structure41Governance41
  • Sep 14, 26StructureA material agreement was terminated+4 more in the same filing8-K 1.02 ↗
  • Sep 8, 26StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Sep 4, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 25, 26StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗
  • Aug 19, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 31, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 15, 26StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
  • May 1, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 3, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 12, 25StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jun 11, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 2, 25StructureA material agreement was terminated+4 more in the same filing8-K 1.02 ↗

4 older filings not shown · The record reaches back to Nov 5, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 7 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Nant Capital, LLC19.9%Sep 14, 26SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Armistice Capital, LLC5.0%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Feb 28, 25Buy$25KStephen C. Glover↗
  • Feb 28, 25Buy$25KGregory Gene Freitag↗

The full record holds 2 transactions and goes back to Jan 5, 23.

Its sector and its market

PDS Biotechnology Corporation among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From PDS Biotechnology Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow PDS Biotechnology Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
727 documents on file, from Apr 18, 2014 to Oct 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.